CBD for Individuals at Risk for Alzheimer's Disease

NCT05822362 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

236

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment

Interventions

DRUG: Cannabidiol
OTHER: Placebo

Sponsor

University of Colorado, Denver